Peptide Dosage Chart: Doses for Every PeRx Peptide
Every peptide PeRx prescribes, in one dosing reference: route, typical dose, and frequency, with a link to the detailed chart for each. Plus the syringe math that turns milligrams into units, and the reason charts from different pharmacies never quite agree.

In this article
Key Takeaways
- Every dose in this chart comes from the detailed PeRx per-peptide dosing pages or the published typical dosing for each product. Your own prescription label overrides all of it.
- Most PeRx peptides are subcutaneous injections drawn with a U-100 insulin syringe, where 100 units equal 1 mL. Two products are oral capsules, and the sublingual GLP-1s are a liquid held under the tongue.
- Syringe units mean nothing without concentration. The conversion is units = (mg divided by the vial mg/mL) times 100, so the same milligram dose becomes a different draw at a different strength.
- PeRx vials arrive ready to use at a fixed, labeled concentration, which is why charts here will not match calculators built for research vendors that sell powder you dissolve yourself.
- Semaglutide and tirzepatide do not follow a fixed chart at all. Dose escalation is a provider-managed titration reviewed at each renewal.
- Some peptides run in defined cycles with planned breaks and others run continuously. The frequency column notes the pattern, and the cycling guide covers the reasoning.
Peptide Dosing Quick Facts
Catalog
24 in-stock peptides and blends across four families
Routes
Mostly subcutaneous injection; two oral capsules; sublingual GLP-1s coming soon
Syringe
U-100 insulin syringe: 100 units = 1 mL
Unit math
units = (mg / vial mg per mL) x 100
Vials
Ship ready to use at a fixed, labeled concentration
Final word
Your prescription label and your provider, always
Peptide Dosage Chart: Every PeRx Peptide
The tables below cover the full PeRx catalog, grouped by family so you can find a product without scrolling one enormous grid. The dose column shows the typical published or clinic pattern behind each product, taken from the detailed per-peptide dosing pages linked in the last column or from the published typical dosing for products that do not have a dedicated chart yet. None of these rows is a menu. A licensed provider reviews your health history before anything is prescribed, and the instructions on your prescription label are the only chart that applies to you.
Two blends, AOD-9604 and the AOD-9604/MOTS-C combination, are currently out of stock and are left out of the tables until they return. Everything else listed is available through a provider consultation.
Repair and Recovery Peptides
| Route | Typical dosing | Frequency | More detail |
|---|---|---|---|
| Subcutaneous injection | 250-500 mcg | Once daily; duration varies by condition | [BPC-157 dosage chart](/blog/bpc-157-dosage-chart) |
| Subcutaneous injection | Per provider guidance | Once daily | [BPC-157 and TB-500 dosage chart](/blog/bpc-157-tb-500-dosage-chart) |
| Subcutaneous injection | 20 units (0.2 mL), 3.8 mg combined peptide per dose | Once daily, Monday through Friday; 6 weeks on, 6 weeks off | [KLOW dosage chart](/blog/klow-peptide-dosage) |
| Oral capsule | Per provider guidance | One capsule daily | [Product page](/peptides/bpc-tb500-capsules) |
| Oral capsule | Per provider guidance | One capsule daily | [Product page](/peptides/bpc-capsules) |
Subcutaneous injection
- Typical dosing
- 250-500 mcg
- Frequency
- Once daily; duration varies by condition
- More detail
- [BPC-157 dosage chart](/blog/bpc-157-dosage-chart)
Subcutaneous injection
- Typical dosing
- Per provider guidance
- Frequency
- Once daily
- More detail
- [BPC-157 and TB-500 dosage chart](/blog/bpc-157-tb-500-dosage-chart)
Subcutaneous injection
- Typical dosing
- 20 units (0.2 mL), 3.8 mg combined peptide per dose
- Frequency
- Once daily, Monday through Friday; 6 weeks on, 6 weeks off
- More detail
- [KLOW dosage chart](/blog/klow-peptide-dosage)
Oral capsule
- Typical dosing
- Per provider guidance
- Frequency
- One capsule daily
- More detail
- [Product page](/peptides/bpc-tb500-capsules)
Oral capsule
- Typical dosing
- Per provider guidance
- Frequency
- One capsule daily
- More detail
- [Product page](/peptides/bpc-capsules)
Growth Hormone and Metabolic Peptides
| Route | Typical dosing | Frequency | More detail |
|---|---|---|---|
| Subcutaneous injection | 20 units (0.2 mL, 600 mcg) | Bedtime, Monday through Friday; 3 months on, 1 month off | [Sermorelin dosage chart](/blog/sermorelin-dosage-chart) |
| Subcutaneous injection | Commonly 5-15 units; 10 units = 120 mcg CJC-1295 + 200 mcg ipamorelin | Before bed, nightly or 5 days on, 2 off | [CJC-1295/Ipamorelin dosage chart](/blog/cjc-1295-ipamorelin-dosage-chart) |
| Subcutaneous injection | 2 mg (67 units) reference dose from the original FDA label | Once daily, same time each day | [Tesamorelin dosage chart](/blog/tesamorelin-dosage-chart) |
| Subcutaneous injection | Per provider guidance | Once daily | [Product page](/peptides/tesamorelin-ipamorelin) |
| Subcutaneous injection | 5-15 mg total per week in common clinic patterns | 2-3 injections per week | [MOTS-c guide with dosing charts](/blog/mots-c-guide) |
Subcutaneous injection
- Typical dosing
- 20 units (0.2 mL, 600 mcg)
- Frequency
- Bedtime, Monday through Friday; 3 months on, 1 month off
- More detail
- [Sermorelin dosage chart](/blog/sermorelin-dosage-chart)
Subcutaneous injection
- Typical dosing
- Commonly 5-15 units; 10 units = 120 mcg CJC-1295 + 200 mcg ipamorelin
- Frequency
- Before bed, nightly or 5 days on, 2 off
- More detail
- [CJC-1295/Ipamorelin dosage chart](/blog/cjc-1295-ipamorelin-dosage-chart)
Subcutaneous injection
- Typical dosing
- 2 mg (67 units) reference dose from the original FDA label
- Frequency
- Once daily, same time each day
- More detail
- [Tesamorelin dosage chart](/blog/tesamorelin-dosage-chart)
Subcutaneous injection
- Typical dosing
- Per provider guidance
- Frequency
- Once daily
- More detail
- [Product page](/peptides/tesamorelin-ipamorelin)
Subcutaneous injection
- Typical dosing
- 5-15 mg total per week in common clinic patterns
- Frequency
- 2-3 injections per week
- More detail
- [MOTS-c guide with dosing charts](/blog/mots-c-guide)
Weight Management: GLP-1 Subscriptions
The GLP-1 rows work differently from everything else on this page. Semaglutide and tirzepatide dosing is a titration: your provider starts you at a strength, reviews how you respond, and adjusts the strength of the vial over time while the injection volume stays familiar. There is no fixed chart to pick from, which is deliberate. One clarification worth a sentence: these are compounded preparations made for an individual patient under a prescription, not the branded pens, and they are not interchangeable with any branded product.
| Route | Typical dosing | Frequency | More detail |
|---|---|---|---|
| Subcutaneous injection | Typically 25 units (0.25 mL) at a provider-set, provider-adjusted strength | Once weekly | [Injection sites for GLP-1s](/blog/where-to-inject-semaglutide-tirzepatide) |
| Subcutaneous injection | Typically 50 units (0.5 mL) at a provider-set, provider-adjusted strength | Once weekly | [Injection sites for GLP-1s](/blog/where-to-inject-semaglutide-tirzepatide) |
| Sublingual liquid | 1 mL held under the tongue 45 seconds, provider-set strength | Once weekly | Coming soon |
| Sublingual liquid | 1 mL held under the tongue 45 seconds, provider-set strength | Once weekly | Coming soon |
Subcutaneous injection
- Typical dosing
- Typically 25 units (0.25 mL) at a provider-set, provider-adjusted strength
- Frequency
- Once weekly
- More detail
- [Injection sites for GLP-1s](/blog/where-to-inject-semaglutide-tirzepatide)
Subcutaneous injection
- Typical dosing
- Typically 50 units (0.5 mL) at a provider-set, provider-adjusted strength
- Frequency
- Once weekly
- More detail
- [Injection sites for GLP-1s](/blog/where-to-inject-semaglutide-tirzepatide)
Sublingual liquid
- Typical dosing
- 1 mL held under the tongue 45 seconds, provider-set strength
- Frequency
- Once weekly
- More detail
- Coming soon
Sublingual liquid
- Typical dosing
- 1 mL held under the tongue 45 seconds, provider-set strength
- Frequency
- Once weekly
- More detail
- Coming soon
Longevity, Immune, Cognitive, and Wellness Peptides
| Route | Typical dosing | Frequency | More detail |
|---|---|---|---|
| Subcutaneous injection | 5-10 mg | Daily, in 10-20 day cycles | [Injection guide](/blog/where-to-inject-epitalon) |
| Subcutaneous injection | Per provider guidance | Provider-set schedule | [Injection guide](/blog/where-to-inject-ghk-cu) |
| Subcutaneous injection | Per provider guidance | Provider-set schedule | [Product page](/peptides/ghk-cu-epitalon) |
| Subcutaneous injection | Per provider guidance | Provider-set schedule | [Injection guide](/blog/where-to-inject-nad-plus) |
| Subcutaneous injection | Commonly 100-200 mg (50-100 units) | 2-3 injections per week | [Glutathione dosage chart](/blog/glutathione-injection-dosage) |
| Subcutaneous injection | 20 units (0.2 mL, 1 mg) | Once daily, Monday through Friday; continuous, no cycling | [Thymosin Alpha-1 dosage chart](/blog/thymosin-alpha-1-dosage) |
| Subcutaneous injection | 250-500 mcg | Once daily | [Injection guide](/blog/where-to-inject-selank) |
| Subcutaneous injection | Per provider guidance | Provider-set schedule | [Product page](/peptides/pinealon-pe2228-selank) |
| Subcutaneous injection | 100-250 mcg | Before bed, as prescribed | [Injection guide](/blog/where-to-inject-dsip) |
| Subcutaneous injection | 1.75 mg, about 45 minutes before anticipated activity | As needed, per label limits | [Injection guide](/blog/where-to-inject-pt-141) |
Subcutaneous injection
- Typical dosing
- 5-10 mg
- Frequency
- Daily, in 10-20 day cycles
- More detail
- [Injection guide](/blog/where-to-inject-epitalon)
Subcutaneous injection
- Typical dosing
- Per provider guidance
- Frequency
- Provider-set schedule
- More detail
- [Injection guide](/blog/where-to-inject-ghk-cu)
Subcutaneous injection
- Typical dosing
- Per provider guidance
- Frequency
- Provider-set schedule
- More detail
- [Product page](/peptides/ghk-cu-epitalon)
Subcutaneous injection
- Typical dosing
- Per provider guidance
- Frequency
- Provider-set schedule
- More detail
- [Injection guide](/blog/where-to-inject-nad-plus)
Subcutaneous injection
- Typical dosing
- Commonly 100-200 mg (50-100 units)
- Frequency
- 2-3 injections per week
- More detail
- [Glutathione dosage chart](/blog/glutathione-injection-dosage)
Subcutaneous injection
- Typical dosing
- 20 units (0.2 mL, 1 mg)
- Frequency
- Once daily, Monday through Friday; continuous, no cycling
- More detail
- [Thymosin Alpha-1 dosage chart](/blog/thymosin-alpha-1-dosage)
Subcutaneous injection
- Typical dosing
- 250-500 mcg
- Frequency
- Once daily
- More detail
- [Injection guide](/blog/where-to-inject-selank)
Subcutaneous injection
- Typical dosing
- Per provider guidance
- Frequency
- Provider-set schedule
- More detail
- [Product page](/peptides/pinealon-pe2228-selank)
Subcutaneous injection
- Typical dosing
- 100-250 mcg
- Frequency
- Before bed, as prescribed
- More detail
- [Injection guide](/blog/where-to-inject-dsip)
Subcutaneous injection
- Typical dosing
- 1.75 mg, about 45 minutes before anticipated activity
- Frequency
- As needed, per label limits
- More detail
- [Injection guide](/blog/where-to-inject-pt-141)
The label governs
Every number above is a reference point, not an instruction. Providers adjust doses for body weight, goals, labs, and response, and the compounding pharmacy prints the result on your vial. When this page and your prescription label disagree, the label wins without exception. If the label itself confuses you, call your provider rather than improvising.
How to Read a Peptide Dosage Chart
A dosing chart is a translator. It exists so that a number quoted in a study, on a forum, or on another pharmacy label can be converted into what it means for the vial in your refrigerator. Reading one well takes three habits. First, check the unit. Signaling peptides like BPC-157 and DSIP are dosed in micrograms (mcg), while larger doses like tesamorelin, MOTS-C, and glutathione are quoted in milligrams (mg). One milligram is 1,000 micrograms, so confusing the two is a thousand-fold error, and it is the single most common mistake people make when comparing charts.
Second, check whether the number is a per-dose amount or a weekly total. MOTS-C clinic patterns are usually quoted as 5 to 15 mg per week split across two or three injections, which is a very different instruction from 15 mg in one sitting. Third, check the concentration the chart assumes, because that is what connects milligrams to the marks on a syringe. The next section does that math once so you never have to trust a chart blindly again.
Where a row above shows a range rather than one number, that range reflects the span of published and clinical practice, not a slider for you to set. Your provider picks the point in the range that fits your case. And where a row says per provider guidance, that is not a dodge: those products, mostly blends, have protocols set individually during the intake review rather than a single published reference dose.
Milligrams, Micrograms, and Insulin-Syringe Units
Injectable PeRx peptides are drawn with a U-100 insulin syringe. U-100 means 100 units per milliliter, so one unit is 0.01 mL of liquid. A unit is a volume, not an amount of peptide. How much peptide rides in each unit depends entirely on the concentration of the vial, which is why the same syringe mark can hold 30 mcg of one product and 2 mg of another.
The only formula you need
units = (dose in mg / vial concentration in mg per mL) x 100. Worked example: sermorelin ships at 3 mg/mL, and the prescribed dose is 600 mcg, which is 0.6 mg. So 0.6 / 3 = 0.2 mL, and 0.2 x 100 = 20 units. Glutathione ships at 200 mg/mL, so each unit holds 2 mg and a 100 mg dose is 50 units. Same syringe, wildly different payloads.
This is also why round syringe numbers show up so often in the tables. A pharmacy that controls the concentration can set it so the prescribed dose lands on an easy mark: 20 units for sermorelin, 20 units for thymosin alpha-1, 20 units for KLOW. A mark you can read at a glance is a dose that is hard to get wrong at eleven at night. Drawing, injecting, and rotating sites are their own skill, and how to inject peptides walks through the mechanics from hand washing to sharps disposal if any of this is new.
Why Charts Differ Between Pharmacies
Search any peptide dose and you will find charts that flatly contradict each other. Usually nobody is lying; they are describing different vials. Research vendors sell peptide as a dry powder that the buyer dissolves at home, which means the concentration is whatever the buyer makes it, and every calculator on those sites exists to solve a problem the buyer created. A prescribed PeRx vial arrives fully reconstituted and ready to use at a fixed concentration chosen by the compounding pharmacy and printed on the label. The units math is done before the box ships, so a chart built for mix-your-own products simply does not transfer.
Branded drugs add their own version of the same confusion. Tesamorelin has carried three different labeled doses since 2010, at 2 mg, 1.4 mg, and 1.28 mg, because the manufacturer changed formulations, not because the FDA cut the dose. The tesamorelin dosage chart untangles that story. The general rule: a dose only means something next to its concentration and formulation. When you see a conflicting number online, the first question is never who is right, it is what vial they are describing.
Cycling and Duration Basics
Dose and frequency are two of the three numbers in a protocol. The third is duration, and it varies more than people expect. Growth hormone peptides like sermorelin typically run 3 months on and 1 month off, giving the pituitary axis a reset and creating a natural checkpoint for repeat labs. KLOW runs 6 weeks on and 6 weeks off. Epitalon runs in short 10 to 20 day cycles. Thymosin alpha-1, by contrast, runs continuously with no washout at all, and the GLP-1s are ongoing therapies reviewed at each monthly renewal rather than cycled.
Which peptides need breaks, which do not, and why is a topic with real physiology behind it, and the peptide cycling guide treats it across the whole catalog. If your question is the mirror image, how long a peptide keeps working after a dose, how long peptides stay in your system separates half-life from duration of effect. Both belong next to any dosage chart, because a dose without a schedule and an endpoint is not a protocol.
Ready to get started?
Licensed providers, pharmaceutical-grade peptides from a US 503A compounding pharmacy, and vials that arrive ready to use with the dose printed on the label. A provider reviews your history and prescribes the protocol that fits your goals.
Peptide Dosage Chart Questions
Related Guides
Continue reading about peptides and protocols that pair well with this guide.
Is Sermorelin FDA Approved? Yes Until 2008
Sermorelin has a unique regulatory history. It was FDA-approved in 1997 as Geref Diagnostic for testing pituitary function, and its therapeutic form (Geref) was used for pediatric growth hormone deficiency. Then the manufacturer discontinued it in 2008. Today Sermorelin is only available as a compounded medication. Here is the full story.
Peptides vs HGH: Safety, Cost, and Results Compared
Direct human growth hormone has been around since the 1980s. Growth hormone peptides like Sermorelin, CJC-1295/Ipamorelin, and Tesamorelin are the modern alternative. The two approaches reach the same destination through completely different routes, with very different safety profiles, cost structures, and outcomes. Here is the honest comparison.
Best Peptides in Tampa: 2026 Tampa Bay Guide
A plain guide to peptide therapy in Tampa for staying active as you age: what it costs across local clinics, concierge services, and telehealth, who tends to use it in a big Gulf-coast metro that never fully retires, and how pharmaceutical-grade peptides reach any Tampa Bay address without a clinic visit.
Medical Disclaimer
The information provided on this website, including all articles, guides, and educational content, is for informational and educational purposes only and is not intended as medical advice, diagnosis, or treatment. Nothing on this site should be construed as a substitute for professional medical advice from a qualified healthcare provider.
The majority of peptides discussed on this site are not approved by the U.S. Food and Drug Administration (FDA) for the indications described. They are classified as bulk drug substances and are available only through a licensed prescribing provider and compounding pharmacy. All treatments require a valid prescription and provider oversight.
The majority of published research on peptide therapies has been conducted in preclinical (animal) models. While early human data is encouraging, comprehensive clinical trial data remains limited for most peptide compounds. Individual results may vary significantly based on health status, injury type, and other factors. No specific outcomes are guaranteed.
Certain peptides discussed on this site are classified as prohibited substances by the World Anti-Doping Agency (WADA) and are banned by major sports organizations including the NFL, NCAA, UFC, NBA, MLB, NHL, and PGA. If you are subject to anti-doping testing, consult your governing body before considering any peptide therapy.
Statements on this website have not been evaluated by the Food and Drug Administration. Products and therapies discussed are not intended to diagnose, treat, cure, or prevent any disease.
© 2026 Wellness MD Group PC DBA PeRx. All rights reserved.